Iain Stuart's Net Worth
$190 Thousand
Who is Iain Stuart?
Iain Stuart does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Foamix Pharmaceuticals Ltd., and VYNE Therapeutics Inc..
SEC CIK
Iain Stuart's CIK is 0001727756
Past Insider Trading and Trends
2018 was Iain Stuart's most active year for acquiring shares with 2 total transactions. Iain Stuart's most active month to acquire stocks was the month of January. 2020 was Iain Stuart's most active year for disposing of shares, totalling 7 transactions. Iain Stuart's most active month to dispose stocks was the month of February. 2019 saw Iain Stuart paying a total of $286,508.69 for 108,566 shares, this is the most they've acquired in one year. In 2018 Iain Stuart cashed out on 3,398 shares for a total of $18,549.34, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Foamix Pharmaceuticals Ltd. No price found
Chief Scientific Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -103.64K |
—
|
—
|
0
|
Mar 9
| |||
Form 4
| +66.25% | 41.3K |
—
|
—
| 103.64K |
Feb 24
| |||
Form 4
| -0.82% | -514.00 |
$3.28 | -$1,685.92 | 62.34K |
Dec 31
| |||
Form 4
| -1.06% | -673.00 |
$3.07 | -$2,066.11 | 62.85K |
Sep 30
| |||
Form 4
| -1.47% | -951.00 |
$2.35 | -$2,234.85 | 63.52K |
Jul 1
| |||
Form 4
| -2.56% | -1.70K |
$3.75 | -$6,360.00 | 64.47K |
Apr 1
| |||
Form 4
| +96.93% | 32.57K |
—
|
—
| 66.17K |
Jan 1
| |||
Form 4
| -1.99% | -683.00 |
$4.58 | -$3,128.14 | 33.6K |
Nov 8
| |||
Form 4
| -7.34% | -2.71K |
$5.68 | -$15,421.20 | 34.28K |
Aug 8
| |||
Form 4
| +37.04% | 10K |
—
|
—
| 37K |
Feb 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
VYNE Therapeutics Inc. (VYNE) Snapshot price: $2.11
CHIEF SCIENTIFIC OFFICER
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -0.12% | -157.00 |
$3.08 | -$483.56 | 133.74K |
Apr 1
| |||
Form 4
| +87.13% | 62.34K |
$2.28 | -$357.96 | 133.9K |
Jan 1 - Jan 2
| |||
Form 4
| +690.23% | 62.5K |
—
|
—
| 71.56K |
Dec 13
| |||
Form 4
| -11.56% | -1.18K |
$3.83 | -$4,534.72 | 9.05K |
Oct 2
| |||
Form 4
| -1.45% | -151.00 |
$4.10 | -$619.10 | 10.24K |
Jun 30
| |||
Form 4
| -4.42% | -480.00 |
$3.08 | -$1,478.40 | 10.39K |
Mar 31
| |||
Form 4
| -0.77% | -1.72K |
$0.15 | -$258.00 | 220.25K |
Dec 31
| |||
Form 4
| -0.77% | -1.72K |
$0.22 | -$383.34 | 221.97K |
Sep 30
| |||
Form 4
| -0.76% | -1.72K |
$0.39 | -$668.69 | 223.69K |
Jun 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||